Lv5
960 积分 2020-04-04 加入
Elucidating the in vivo fate of pharmaceutical excipient sodium carboxymethylcellulose in rats using UHPLC- Q TRAP MS/MS and UHPLC- Q TOF MS/MS approach
8天前
已完结
〈1106〉 Immunogenicity Assays—Design and Validation of Immunoassays to Detect Anti-Drug Antibodies
13天前
已关闭
〈1106.1〉 Immunogenicity Assays—Design and Validation of Assays to Detect Anti-Drug Neutralizing Antibody
13天前
已关闭
From ADA positivity to clinical decision: a context-of-use framework for reflex testing, sampling frequency and stopping rules in immunogenicity assessment
1个月前
已完结
Immunogenicity Assays Used in Support of Marketing Applications of Oligonucleotide Therapeutics
1个月前
已完结
Label-free SERS for the detection of renal failure biomarkers in blood serum using gold nanoparticles as a substrate
1个月前
已完结
Consideration for immunogenicity assay development for oligonucleotide therapeutics
1个月前
已完结
Investigating the relationship between relative accuracy and linearity acceptance criteria in bioassay validation for clinical studies
1个月前
已完结
Development of a ready-to-use cell-based functional neutralizing antibody assay for MK-1484, a PEGylated IL-2 mutein that preferentially activates effector T-cells
1个月前
已完结
A validated bioanalytical LC-MS/MS method for the simultaneous determination of molnupiravir, N-hydroxycytidine, and baricitinib in human plasma
1个月前
已完结
皖公网安备34019202002308
